XOMA Royalty (XOMA) FCF Payout Ratio (2021 - 2026)

XOMA Royalty's (XOMA) quarterly FCF Payout Ratio came in at 0.23 in Q1 2026, down 62.62% year-on-year from 0.62 in Q1 2025, and up 193.55% quarter-over-quarter from 0.25 in Q4 2025.

XOMA Royalty (XOMA) FCF Payout Ratio (2021 - 2026) Analysis & Trends

XOMA Royalty has disclosed FCF Payout Ratio across 6 years of filings, most recently posting 0.23 for Q1 2026.

  • FCF Payout Ratio for Q1 2026 came in at 0.23, down 62.62% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.81 (up 198.23% YoY), and the FY2025 annual result was 1.91, up 579.55% from the prior year.
  • FCF Payout Ratio came in at 0.23 for Q1 2026 at XOMA Royalty, up from 0.25 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 0.62 in Q1 2025 to a low of 4.62 in Q3 2025.
  • The 5-year median for FCF Payout Ratio is 0.28 (2023), against an average of 0.47.
  • Across the five-year window, FCF Payout Ratio surged 364.32% in 2024 and plunged 2813.85% in 2025, its largest moves.
  • XOMA Royalty's FCF Payout Ratio stood at 0.35 in 2022, then grew by 0.94% to 0.35 in 2023, then plunged by 35.13% to 0.47 in 2024, then jumped by 47.17% to 0.25 in 2025, then jumped by 193.55% to 0.23 in 2026.
  • The last three FCF Payout Ratio figures came in at 0.23 (Q1 2026), 0.25 (Q4 2025), and 4.62 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 0.23

Historic Data

Download Data
DateValue
Mar 31, 2026 0.23
Dec 31, 2025 -0.25
Sep 30, 2025 -4.62
Jun 30, 2025 0.21
Mar 31, 2025 0.62
Dec 31, 2024 -0.47
Sep 30, 2024 -0.16
Jun 30, 2024 0.50
Mar 31, 2024 -0.28
Dec 31, 2023 -0.35
Sep 30, 2023 -0.65
Jun 30, 2023 -0.19
Mar 31, 2023 -0.28
Dec 31, 2022 -0.35
Sep 30, 2022 -0.37
Jun 30, 2022 -0.32
Mar 31, 2022 -1.36
Dec 31, 2021 0.04
Sep 30, 2021 -0.46